Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Fibroblast Growth Factor 23 as a Prognostic Biomarker in Post-Myocardial Infarction Outcomes: Influence of Renal Function and Its Modulation by Klotho.

  • Vázquez-Sánchez, Sara
  • Blasco, Ana
  • Polo-Salguero, Marina
  • Mourino-Álvarez, Laura
  • Gil-Fernández, Marta
  • Corbacho-Alonso, Nerea
  • Navarro-García, José Alberto
  • Mercado-García, Elisa
  • González-Lafuente, Laura
  • Rodríguez-Sánchez, Elena
  • González-Moreno, Daniel
  • Pérez-Gómez, Alberto
  • Matutano, Andrea
  • Vázquez, Jesús
  • López, Juan Antonio
  • Fernández-Velasco, María
  • Barderas, María G
  • Ruiz-Hurtado, Gema
Elevation of FGF23 (fibroblast growth factor 23) and decreased Klotho levels have been associated with various cardiovascular and renal diseases. However, the combined study of the FGF23-Klotho axis in ischemic heart disease remains elusive. We analyzed the associations between circulating FGF23 and Klotho levels with cardiac and renal parameters, as well as mortality outcomes following myocardial infarction (MI). Cardiac tissue from patients with ischemic heart disease and a post-MI mouse model were analyzed to assess myocardial FGF23 expression. Proteomic analysis was performed to examine myocardial pathways activated by FGF23 and regulated by Klotho. We observed an inverse correlation between circulating levels of FGF23 and Klotho in patients after MI. Elevated plasma FGF23 levels were particularly associated with ST-segment-elevation MI and cardiac dysfunction, including reduced left ventricular ejection fraction, prolonged corrected interval, and higher Killip-Kimball classification of cardiac risk, identifying FGF23 as a potential prognostic marker of overall and cardiac-related mortality. In contrast, systemic Klotho levels were reduced in patients with ST-segment-elevation MI but did not correlate with mortality. In cardiac tissue, ischemic injury significantly upregulated FGF23 expression. Although Klotho prevented FGF23-induced proteomic alterations, it did not inhibit cardiac FGF23 overexpression in the post-MI model. FGF23 represents a promising biomarker for mortality and cardiac dysfunction in patients with MI. Although Klotho does not appear to be a reliable predictor of mortality after MI, its cardioprotective properties suggest a role in modulating FGF23-driven metabolic, structural, and proliferative processes in the myocardium.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The Mediterranean Diet is Associated with an Improved Quality of Life in Adults with Type 1 Diabetes

  • Granado-Casas, Minerva|||0000-0003-3447-5728
  • Martín, Mariona
  • Martinez-Alonso, Montserrat|||0000-0003-1504-8552
  • Alcubierre, Nuria|||0000-0001-6245-3599
  • Hernández García, Marta|||0000-0003-1237-298X
  • Alonso Pedrol, Núria|||0000-0001-9687-8050
  • Castelblanco, Esmeralda|||0000-0002-2061-6270
  • Mauricio, Didac|||0000-0002-2868-0250
This study aimed to assess the potential association between dietary patterns (i.e., the Mediterranean Diet (MedDiet) and healthy eating) and patient-reported quality of life (QoL) and treatment satisfaction (TS) in adults with type 1 diabetes (T1D). A food frequency questionnaire, the Audit of Diabetes-Dependent Quality of Life (ADDQoL-19), and the Diabetes Treatment Satisfaction Questionnaire-status version (DTSQ-s) were administered via personal interviews to 258 participants with T1D. Multivariable analysis showed that a moderate or high adherence to the MedDiet was associated with greater diabetes-specific QoL (β = 0.32, 95% CI = 0.03; 0.61; p = 0.029). None of the dietary quality indexes (i.e., the alternate Mediterranean Diet Score (aMED) and the alternate Healthy Eating Index (aHEI)) were associated with the overall TS. However, the aHEI was positively associated with the specific items of TS "convenience" and "flexibility" (β = 0.03, 95% CI = 0.00; 0.06; p = 0.042 and β = 0.04; 95% CI = 0.01; 0.06; p = 0.011, respectively). On the other hand, the aHEI was negatively associated with the dimension "recommend to others" (β = -0.5, 95% CI = -0.99; -0.02; p = 0.042). In conclusion, a moderate and high adherence to the MedDiet was associated with greater QoL. Although neither aMED nor aHEI were associated with the overall TS, some specific items were positively (i.e., "convenience", "flexibility") or negatively ("recommend to others") related to the aHEI. Further research is needed to assess how to improve medical nutrition therapy and its impact on patient-reported outcomes in people with T1D.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Spanish People with Type 2 Diabetes Show an Improved Adherence to the Mediterranean Diet

  • Alcubierre, Nuria|||0000-0001-6245-3599
  • Granado-Casas, Minerva|||0000-0003-3447-5728
  • Real, Jordi|||0000-0002-5979-8948
  • Perpiñán, Hèctor
  • Rubinat, Esther|||0000-0003-0232-9777
  • Falguera, Mireia|||0000-0002-7846-8952
  • Castelblanco, Esmeralda|||0000-0002-2061-6270
  • Franch-Nadal, Josep|||0000-0002-5175-1555
  • Mauricio, Didac|||0000-0002-2868-0250
The aim of this study was to assess the dietary pattern (i.e., Mediterranean Diet (MedDiet) and healthy eating) in people with type 2 diabetes (T2D) compared with those without diabetes. In addition, we explored clinical factors associated with the dietary pattern. This cross-sectional study was performed with a sample of 476 participants (238 with T2D and 238 participants without diabetes, matched for age and sex). The alternate Mediterranean Diet (aMED) score and the alternate Healthy Eating Index (aHEI) were calculated. Statistical analysis included comparison between groups and multivariable models. Participants with T2D showed higher aMED and aHEI scores (mean (SD): 4.3 (1.5) and 43.9 (6.5), respectively) in comparison with the control group (3.5 (1.8) and 39.4 (7.4), respectively; p < 0.001). In addition, a higher proportion of participants with T2D in higher tertiles of aMED (21.8%) and aHEI (39.9%) was observed compared with participants without diabetes (11.3% for the aMED, and 19.3% for the aHEI; p < 0.001). The adjusted multivariable analysis revealed that T2D (p < 0.001), increasing age (p = 0.006 and p = 0.030, respectively), and physical activity (p = 0.009) were positively associated with higher aMED and aHEI scores. Dyslipidemia and female gender were positively associated with aMED and aHEI (p = 0.031 and p < 0.001, respectively). The specific multivariable analysis for the group with T2D yielded a positive association of age (p < 0.001) and dyslipidemia (p = 0.021) with aMED. Regarding the aHEI, only female gender was positively related with this score in diabetes participants (p = 0.025). Participants with T2D showed a higher adherence to the MedDiet and a healthier eating pattern.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Type 1 Diabetic Subjects with Diabetic Retinopathy Show an Unfavorable Pattern of Fat Intake

  • Granado-Casas, Minerva|||0000-0003-3447-5728
  • Ramírez-Morros, Anna|||0000-0001-8263-1292
  • Martín, Mariona
  • Real, Jordi|||0000-0002-5979-8948
  • Alonso Pedrol, Núria|||0000-0001-9687-8050
  • Valldeperas Belmonte, Xavier|||0000-0002-6343-6405
  • Traveset, Alicia|||0000-0003-2703-326X
  • Rubinat, Esther|||0000-0003-0232-9777
  • Alcubierre, Nuria|||0000-0001-6245-3599
  • Hernández García, Marta|||0000-0003-1237-298X
  • Puig Domingo, Manuel|||0000-0002-6744-7195
  • Lecube, Albert|||0000-0001-9684-0183
  • Castelblanco, Esmeralda|||0000-0002-2061-6270
  • Mauricio, Didac|||0000-0002-2868-0250
Medical nutrition therapy is an important part of the management of type 1 diabetes mellitus (T1DM). Proper adherence to a healthy diet may have a favorable impact on diabetes management and its diabetic complications. Our aim was to assess differences in food and nutrient intake of type 1 diabetic patients with and without diabetic retinopathy (DR). This was a two-center, cross-sectional study in patients with T1DM, with and without DR. Subjects were recruited from the outpatient clinic of the two participating centers. A validated food frequency questionnaire was administered. A total of 103 T1DM patients with DR and 140 T1DM patient without DR were recruited. Subjects with DR showed a lower intake of total fat (p = 0.036) than that of their non-DR counterparts. DR was associated with increasing age (p = 0.004), hypertension (p < 0.001), and diabetes duration (p < 0.001), however there was a negative association with high educational level (p = 0.018). The multivariate-adjusted analysis showed that the intake of complex carbohydrates was positively related to the presence of DR (p = 0.031). In contrast, the intakes of total fat (p = 0.009), monounsaturated fatty acids (MUFAs) (p = 0.012), oleic acid (p = 0.012), and vitamin E (p = 0.006) were associated with the absence of DR. As conclusions, the intake of total MUFAs, oleic acid, and vitamin E is associated with a lower frequency of DR in patients with T1DM. These results suggest a potential protective effect of these lipid components for DR.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Psychometric validation of the cardiff wound impact schedule questionnaire in a spanish population with diabetic foot ulcer

  • Granado-Casas, Minerva|||0000-0003-3447-5728
  • Martinez-Gonzalez, Dolores
  • Martinez-Alonso, Montserrat|||0000-0003-1504-8552
  • Dòria, Montserrat|||0000-0001-8477-1942
  • Alcubierre, Nuria|||0000-0001-6245-3599
  • Valls, Joan|||0000-0002-4806-7568
  • Julve i Gil, Josep|||0000-0002-6531-2246
  • Verdú-Soriano, José|||0000-0002-8307-7323
  • Mauricio, Didac|||0000-0002-2868-0250
Diabetic foot ulcers (DFU) negatively affect the quality of life (QoL) of people with diabetes. The Cardiff Wound Impact Schedule (CWIS) questionnaire has been designed to measure the QoL of people with chronic foot wounds. However, no studies have been specifically designed to validate this instrument in a Spanish population. In this prospective study, a total of 141 subjects with DFU were recruited. DFU was determined by performing physical examinations. Medical records were exhaustively reviewed to collect clinical variables. The CWIS was transculturally adapted by a group of experts and a group of patients with DFU. The SF-36 and EQ-5D generic instruments were used as reference tools. The questionnaires were administered at 7 days and 4, 12, and 26 weeks after the baseline assessment by personal interview with each of the study subjects. The psychometric properties of the instrument were assessed using statistical methods. The content validity had an average of 3.63 (90.7% of the maximum score of 4). The internal consistency of the CWIS subscales had a standardized Cronbach's alpha range from 0.715 to 0.797. The reproducibility was moderate with an intraclass correlation coefficient (ICC) range from 0.606 to 0.868. Significant correlations between CWIS domains and SF-36 and EQ-5D subscales were observed, demonstrating a good criterion validity of the CWIS questionnaire (p < 0.001). However, the construct validity of the CWIS was not validated with a comparative fit index (CFI) of 0.69, a root mean square error of approximation (RMSEA) of 0.09, and a standardized root mean square residual (SRMR) of 0.10. The sensitivity to changes over time was optimal in the three domains (i.e., social life, well-being, and physical symptoms) (p < 0.001). In conclusion, the Spanish version of the CWIS shows acceptable psychometric properties to assess the QoL of subjects with DFU, except for its construct validity.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Caffeine and the Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus, Findings from Clinical and Experimental Studies

  • Alcubierre, Nuria|||0000-0001-6245-3599
  • Granado-Casas, Minerva|||0000-0003-3447-5728
  • Bogdanov, Patricia|||0000-0003-0669-4958
  • Hernández, Cristina|||0000-0002-3109-1721
  • Ramos, Hugo|||0000-0001-6443-7576
  • Castelblanco, Esmeralda|||0000-0002-2061-6270
  • Real, Jordi|||0000-0002-5979-8948
  • Rubinat, Esther|||0000-0003-0232-9777
  • Traveset, Alicia|||0000-0003-2703-326X
  • Hernández García, Marta|||0000-0003-1237-298X
  • Jurjo, Carmen
  • Vioque, Jesús|||0000-0002-2284-148X
  • Navarrete-Muñoz, Eva María|||0000-0002-1494-5676
  • Simó Canonge, Rafael|||0000-0003-0475-3096
  • Mauricio, Didac|||0000-0002-2868-0250
The aim of this study was to assess the potential benefits of caffeine intake in protecting against the development of diabetic retinopathy (DR) in subjects with type 2 diabetes (T2D). Furthermore, we tested the effect of topical administration of caffeine on the early stages of DR in an experimental model of DR. In the cross-sectional study, a total of 144 subjects with DR and 147 individuals without DR were assessed. DR was assessed by an experienced ophthalmologist. A validated food frequency questionnaire (FFQ) was administered. In the experimental model, a total of 20 mice were included. One drop (5 μL) of caffeine (5 mg/mL) (n = 10) or vehicle (5 μL PBS, pH 7.4) (n = 10) was randomly administered directly onto the superior corneal surface twice daily for two weeks in each eye. Glial activation and retinal vascular permeability were assessed using standard methods. In the cross-sectional study in humans, the adjusted-multivariable model showed that a moderate and high (Q2 and Q4) caffeine intake had a protective effect of DR (odds ratio (95% confidence interval) = 0.35 (0.16-0.78); p = 0.011 and 0.35 (0.16-0.77); p = 0.010, respectively). In the experimental model, the administration of caffeine did not improve either reactive gliosis or retinal vascular permeability. Our results suggest a dose-dependent protective effect of caffeine in the development of DR, while the potential benefits of antioxidants in coffee and tea should also be considered. Further research is needed to establish the benefits and mechanisms of caffeinated beverages in the development of DR.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Poorer quality of life and treatment satisfaction is associated with diabetic retinopathy in patients with type 1 diabetes without other advanced late complications

  • Granado-Casas, Minerva|||0000-0003-3447-5728
  • Castelblanco, Esmeralda|||0000-0002-2061-6270
  • Ramírez-Morros, Anna|||0000-0001-8263-1292
  • Martín, Mariona
  • Alcubierre, Nuria|||0000-0001-6245-3599
  • Martínez-Alonso, M.
  • Valldeperas Belmonte, Xavier|||0000-0002-6343-6405
  • Traveset, Alicia|||0000-0003-2703-326X
  • Rubinat, Esther|||0000-0003-0232-9777
  • Lucas Martín, Anna
  • Hernández García, Marta|||0000-0003-1237-298X
  • Alonso Pedrol, Núria|||0000-0001-9687-8050
  • Mauricio, Didac|||0000-0002-2868-0250
Diabetic retinopathy (DR) may potentially cause vision loss and affect the patient's quality of life (QoL) and treatment satisfaction (TS). Using specific tools, we aimed to assess the impact of DR and clinical factors on the QoL and TS in patients with type 1 diabetes. This was a cross-sectional, two-centre study. A sample of 102 patients with DR and 140 non-DR patients were compared. The Audit of Diabetes-Dependent Quality of Life (ADDQoL-19) and Diabetes Treatment Satisfaction Questionnaire (DTSQ-s) were administered. Data analysis included bivariate and multivariable analysis. Patients with DR showed a poorer perception of present QoL (p = 0.039), work life (p = 0.037), dependence (p = 0.010), and had a lower average weighted impact (AWI) score (p = 0.045). Themultivariable analysis showed that DR was associated with a lower present QoL (p = 0.040), work life (p = 0.036) and dependence (p = 0.016). With regards to TS, DR was associated with a higher perceived frequency of hypoglycaemia (p = 0.019). In patients with type 1 diabetes, the presence of DR is associated with a poorer perception of their QoL.With regard to TS, these subjects also show a higher perceived frequency of hypoglycaemia.